Robert Paul
Chief Executive Officer chez Nine Square Therapeutics, Inc.
Profil
Robert Paul is currently the Chief Executive Officer at Nine Square Therapeutics, Inc. He previously worked as the Chief Medical Officer at Alector, Inc. from 2016 to 2021 and as the Assistant Director-Group Medical at Genentech, Inc. from 2015 to 2016.
Dr. Paul holds a doctorate degree from Ludwig-Maximilians-Universität München.
Postes actifs de Robert Paul
| Sociétés | Poste | Début |
|---|---|---|
Nine Square Therapeutics, Inc.
 Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Nine Square Therapeutics, Inc. provides biotechnology services. The company was founded in 2020 and is headquartered in New York, NY. | Chief Executive Officer | 11/01/2022 |
Anciens postes connus de Robert Paul
| Sociétés | Poste | Fin |
|---|---|---|
| ALECTOR, INC. | Chief Tech/Sci/R&D Officer | 11/10/2021 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/10/2016 |
Formation de Robert Paul
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALECTOR, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Nine Square Therapeutics, Inc.
Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Nine Square Therapeutics, Inc. provides biotechnology services. The company was founded in 2020 and is headquartered in New York, NY. | Health Technology |
